HRP20040781B8 - Process for the preparation of high purity perindopril and intermediates useful in the synthesis - Google Patents

Process for the preparation of high purity perindopril and intermediates useful in the synthesis

Info

Publication number
HRP20040781B8
HRP20040781B8 HR20040781A HRP20040781A HRP20040781B8 HR P20040781 B8 HRP20040781 B8 HR P20040781B8 HR 20040781 A HR20040781 A HR 20040781A HR P20040781 A HRP20040781 A HR P20040781A HR P20040781 B8 HRP20040781 B8 HR P20040781B8
Authority
HR
Croatia
Prior art keywords
formula
compound
preparation
reacting
alkyl
Prior art date
Application number
HR20040781A
Other languages
English (en)
Croatian (hr)
Inventor
Simig Gyula
Mezei Tibor
Porcs-Makkay Marta
Mandi Attila
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20040781A2 publication Critical patent/HRP20040781A2/xx
Publication of HRP20040781B1 publication Critical patent/HRP20040781B1/xx
Publication of HRP20040781A8 publication Critical patent/HRP20040781A8/xx
Publication of HRP20040781B8 publication Critical patent/HRP20040781B8/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20040781A 2002-01-30 2004-08-27 Process for the preparation of high purity perindopril and intermediates useful in the synthesis HRP20040781B8 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02290206A EP1333026B1 (en) 2002-01-30 2002-01-30 Process for the preparation of high purity perindopril and intermediates useful in the synthesis
PCT/IB2003/000691 WO2003064388A2 (en) 2002-01-30 2003-01-29 Process for the preparation of high purity perindopril and intermediates useful in the synthesis

Publications (4)

Publication Number Publication Date
HRP20040781A2 HRP20040781A2 (en) 2004-12-31
HRP20040781B1 HRP20040781B1 (en) 2008-12-31
HRP20040781A8 HRP20040781A8 (en) 2009-01-31
HRP20040781B8 true HRP20040781B8 (en) 2009-01-31

Family

ID=8185713

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040781A HRP20040781B8 (en) 2002-01-30 2004-08-27 Process for the preparation of high purity perindopril and intermediates useful in the synthesis

Country Status (36)

Country Link
US (2) US7326794B2 (ko)
EP (1) EP1333026B1 (ko)
JP (1) JP4171423B2 (ko)
KR (1) KR100673701B1 (ko)
CN (1) CN1300111C (ko)
AP (1) AP1741A (ko)
AR (1) AR038340A1 (ko)
AT (1) ATE365714T1 (ko)
AU (1) AU2003206055B2 (ko)
BG (1) BG66126B1 (ko)
BR (2) BRPI0307293B1 (ko)
CA (1) CA2474003C (ko)
CY (1) CY1106721T1 (ko)
CZ (1) CZ305892B6 (ko)
DE (1) DE60220877T2 (ko)
DK (1) DK1333026T3 (ko)
EA (1) EA009277B1 (ko)
EE (1) EE05428B1 (ko)
ES (1) ES2289060T3 (ko)
GE (1) GEP20063899B (ko)
HK (1) HK1076101A1 (ko)
HR (1) HRP20040781B8 (ko)
HU (1) HU227591B1 (ko)
ME (1) ME00444B (ko)
MX (1) MXPA04007444A (ko)
NO (1) NO330223B1 (ko)
NZ (1) NZ534168A (ko)
OA (1) OA12759A (ko)
PL (1) PL212354B1 (ko)
PT (1) PT1333026E (ko)
RS (1) RS52465B (ko)
SI (1) SI1333026T1 (ko)
SK (1) SK287866B6 (ko)
UA (1) UA77756C2 (ko)
WO (1) WO2003064388A2 (ko)
ZA (1) ZA200405548B (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037788A1 (en) * 2003-10-21 2005-04-28 Lupin Ltd. Novel method for preparation of crystalline perindopril erbumine
SI21704A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd New crystal form of perindopril, procedure of its preparation, pharmaceutical preparations containing this form and their application in treatment of hypertensia
JP4948392B2 (ja) * 2004-03-29 2012-06-06 レ ラボラトア セルビエ 固形薬学的組成物を調製するためのプロセス
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
ES2255872B1 (es) * 2004-12-31 2007-08-16 Quimica Sintetica, S.A. Procedimiento para la preparacion de perindopril erbumina.
SI1679072T1 (sl) 2005-01-06 2009-02-28 Ipca Lab Ltd Postopek za sintezo derivatov (2S,3aS,7aS)-1-(S)-alanil-oktahidro-1H-indol-2-karboksilne kisline inuporaba v sintezi perindoprila
US7710739B2 (en) 2005-04-28 2010-05-04 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device and display device
WO2006137082A1 (en) * 2005-06-23 2006-12-28 Ramesh Babu Potluri Process for industrially viable preparation of perindopril erbumine
US20070032661A1 (en) * 2005-08-03 2007-02-08 Glenmark Pharmaceuticals Limited Process for the preparation of intermediates of perindopril
AU2006281684B2 (en) * 2005-08-12 2012-08-02 Lek Pharmaceuticals D.D. A process for the preparation of perindopril erbumine
EP1792896A1 (en) * 2005-12-01 2007-06-06 KRKA, tovarna zdravil, d.d., Novo mesto Process for the preparation of perindopril and salts thereof
KR101396899B1 (ko) * 2006-05-12 2014-05-19 에지스 지오기스제르기아르 니일바노산 무코도 레스즈베니타르사사그 Ace-억제제의 합성에서의 약학적 중간체 및 이의 용도
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK144769C (da) 1979-12-06 1982-12-13 Voelund Vaskerimaskiner Tromlevaskemaskine med varmeveksler
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
US4565819A (en) * 1979-12-07 1986-01-21 Adir Substituted imino diacids, their preparation and pharmaceutical compositions which contain them
IN156096B (ko) 1981-03-19 1985-05-11 Usv Pharma Corp
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
SI9600169A (en) 1996-05-22 1997-12-31 Krka Tovarna Zdravil Process for preparation of compounds with ace inhibitory effect
FR2807431B1 (fr) 2000-04-06 2002-07-19 Adir Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
FR2827860B1 (fr) * 2001-07-24 2004-12-10 Servier Lab Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril
AR036187A1 (es) * 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario

Also Published As

Publication number Publication date
CN1622936A (zh) 2005-06-01
EA009277B1 (ru) 2007-12-28
RS66704A (en) 2007-02-05
US7279595B2 (en) 2007-10-09
HK1076101A1 (en) 2006-01-06
BG108858A (en) 2005-05-31
HU0300231D0 (en) 2003-03-28
CY1106721T1 (el) 2012-05-23
KR100673701B1 (ko) 2007-01-24
ES2289060T3 (es) 2008-02-01
DE60220877T2 (de) 2008-04-10
CZ305892B6 (cs) 2016-04-27
HRP20040781A8 (en) 2009-01-31
PL212354B1 (pl) 2012-09-28
HRP20040781A2 (en) 2004-12-31
EP1333026A1 (en) 2003-08-06
BR0307293A (pt) 2004-12-21
UA77756C2 (uk) 2007-01-15
EE200400107A (et) 2004-10-15
GEP20063899B (en) 2006-08-10
NO20043472L (no) 2004-08-20
CZ2004906A3 (cs) 2004-12-15
DK1333026T3 (da) 2007-10-22
RS52465B (en) 2013-02-28
JP4171423B2 (ja) 2008-10-22
SK287866B6 (sk) 2012-02-03
KR20040078680A (ko) 2004-09-10
AR038340A1 (es) 2005-01-12
PT1333026E (pt) 2007-09-17
AU2003206055B2 (en) 2008-07-17
EP1333026B1 (en) 2007-06-27
ZA200405548B (en) 2006-09-27
HUP0300231A2 (hu) 2003-08-28
SK3292004A3 (en) 2004-12-01
WO2003064388A3 (en) 2004-02-05
AP2004003091A0 (en) 2004-09-30
ME00444B (me) 2011-10-10
BRPI0307293B1 (pt) 2018-03-06
US20070197821A1 (en) 2007-08-23
US7326794B2 (en) 2008-02-05
NO330223B1 (no) 2011-03-07
AP1741A (en) 2007-05-16
EE05428B1 (et) 2011-06-15
ATE365714T1 (de) 2007-07-15
DE60220877D1 (de) 2007-08-09
NZ534168A (en) 2006-11-30
BG66126B1 (bg) 2011-06-30
HU227591B1 (hu) 2011-09-28
EA200400929A1 (ru) 2005-06-30
CA2474003C (en) 2009-06-02
WO2003064388A2 (en) 2003-08-07
PL358514A1 (en) 2003-07-28
HUP0300231A3 (en) 2004-04-28
CA2474003A1 (en) 2003-08-07
US20050119492A1 (en) 2005-06-02
HRP20040781B1 (en) 2008-12-31
MXPA04007444A (es) 2005-06-17
CN1300111C (zh) 2007-02-14
OA12759A (en) 2006-07-04
JP2005521667A (ja) 2005-07-21
SI1333026T1 (sl) 2007-10-31

Similar Documents

Publication Publication Date Title
HRP20040781B8 (en) Process for the preparation of high purity perindopril and intermediates useful in the synthesis
Qiao et al. 5-Amidinobenzo [b] thiophenes as dual inhibitors of factors IXa and Xa
HK1004481A1 (en) Depsipeptide derivative, production thereof and use thereof
TNSN05140A1 (en) Perindopril
ATE399753T1 (de) Amide als pyruvatdehydrogenaseinhibitoren
HUT68056A (en) Substituted indoles and azaindoles as angiotensin ii antagonists, pharmaceutical compositions containing same, process for their production and intermediates
HRP20030566B1 (en) Improved process for carbapenem synthesis
TW200510299A (en) Organic compounds
AU2003242144A1 (en) Processes for producing epoxytriazole derivative and intermediate therefor
IS5497A (is) Bífenýlamidínafleiður
DE60335865D1 (de) Verfahren zur herstellung von cilostazol
PA8525601A1 (es) Profarmacos de (3s,4s)-4-bencil-1-[2-(4-hidroxi-bencenosulfonil)-etil]-piperidin-3-ol
AU714155B2 (en) Process for synthesizing carbapenem side chain intermediates
WO2004099138A3 (en) Process for the preparation of perindopril
EP1557418A4 (en) NEW CHINOXALINE DERIVATIVES
JPH0317051A (ja) シクロプロパノイルアミノ酸アミド誘導体
FI944207A0 (fi) Cyclohexane derivatives
JPS63238056A (ja) ベンズアルドキシム誘導体
MY136639A (en) New process for the synthesis of (2s, 3as, 7as)-perhydroindole-2-carboxylic acid and esters thereof, and application in the synthesis of perindopril
WO2000012465A3 (de) Cycloalkylcarbonsäureamide, deren herstellung und verwendung als fungizide im agrarbereich

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
A8IS Corrected front page of an hr-a document
B8IS Corrected front page of an hr-b document
ODRP Renewal fee for the maintenance of a patent

Payment date: 20181210

Year of fee payment: 17

PBON Lapse due to non-payment of renewal fee

Effective date: 20200129